Equity Overview
Price & Market Data
Price: $7.30
Daily Change: +$0.07 / 0.96%
Daily Range: $7.06 - $7.39
Market Cap: $170,059,344
Daily Volume: 133,026
Performance Metrics
1 Week: -0.68%
1 Month: 2.24%
3 Months: 5.04%
6 Months: 38.26%
1 Year: 49.90%
YTD: 86.70%
Company Details
Employees: 41
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.